Another study showed a correlation between the ability of mouse tumor cell lines to consume oxygen and produce hypoxic environments with their sensitivity to PD-1 checkpoint blockade [125], thus suggesting that decreased levels of ROS and consequently a less hypoxic TME may intensify the effectiveness of PD-1 blockade immunotherapy. This evidence concerns the gene PDCD1 and neoplasm.